RE: An honest post3 Feb 2021 21:05
Harchris yeah I think we all believe, as does the science on our scientists that ifn given earlier will be more beneficial. Good idea to see how p2 home trial UK/US turns out before derisking a little. There is more possibility of a lesser success this time round due to the lack of control the team have and the multiple ethnicities and countries we are trialing in. However, as some have said before, anything more than 30% (dexa) will still be seen as a good result in the science world, just maybe not in the investment world where they are going to want us to replicate the p2 efficacy.